NORML
OCTOBER 21, 2019
The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials. However, most of those applications have been before DEA for several years, and the agency still has yet to provide any explicit timeline regarding when, if ever it intends to act on them.
The Cannigma
MAY 19, 2021
However, the country has a history of cannabis art dating back millenia , and scholars believe that the plant was used for centuries as a textile and for use in traditional Shinto ceremonies. Nearly a decade earlier, i n 2011 a Tokyo musician was arrested after a small bag fell out of his pants in a convenient store.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Freedom Leaf
JULY 20, 2017
Researchers at the Georgia State University School of Public Health assessed the association between cannabis use duration and MetS in a cohort of 3,051 adults who participated in the National Health and Nutrition Examination Survey (NHANES) in 2011-2012.
Cannabis Law Report
FEBRUARY 28, 2022
Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. 640, 640 (2011). Trial of Psilocybin Versus Escitalopram for Depression , 384 NEW ENG.
Cannabis Law Report
JUNE 11, 2019
He had a history of drug use both before and after the accidents that included cocaine, heroin, and crystal meth. At the time of trial, McCallum was on methadone and medical marijuana. Gordon had a significant history of drug use. The absence of a history of recreational drug use, or of drug dependency problems.
SMPL
MAY 26, 2020
There was a strong sense that this was really going to be something, if when people use these strains they have any kind of experience like the mice did in the laboratories,” said Martin Lee, a writer who at the time had been finishing a book about the social history of marijuana for Simon & Schuster.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history.
Expert insights. Personalized for you.
104 
Let's personalize your content